Thank you for registering your interest in our presbyopia clinical trial. A member of the research team will be in touch within 2 business days to discuss the study with you.
What is the study for?
This study is assessing whether an experimental eye medication can improve the vision of people with presbyopia.
The study is a Phase I/II clinical trial.
- 3 visits to our Sippy Downs centre
- 8 days of study treatment
- Medical and optical assessments
- Self-administration of the study medication when not attending the clinic
The study treatment is an eye drop applied to your eyes. On days involving a clinic visit, trained personnel will administer the study treatment. On other days, the drops are self-administered.
This is a placebo controlled and blinded study, which means you won't know whether you receive the eye medication or placebo.
The research team will sit down with you and go through the study criteria, as well as your medical history, ocular history, and current and past medications. There will be some medical and optical examinations to help determine your eligibility for the study.
You will be required to present a valid form of ID at each visit.
All study procedures are at no cost to you, and you will be compensated for your time and travel expenses.
Where can I find more information?
More information can be requested by contacting the research site to the right. Alternatively, the research team will be more than happy to answer any questions you may have when they call.
HREC approval: Bellberry Human Research Ethics Committee